Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Assets (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Assets for 16 consecutive years, with $16.3 million as the latest value for Q4 2025.

  • Quarterly Assets rose 146.12% to $16.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.3 million through Dec 2025, up 146.12% year-over-year, with the annual reading at $16.3 million for FY2025, 146.12% up from the prior year.
  • Assets for Q4 2025 was $16.3 million at Plus Therapeutics, down from $18.7 million in the prior quarter.
  • The five-year high for Assets was $24.8 million in Q3 2021, with the low at $5.6 million in Q1 2024.
  • Average Assets over 5 years is $15.7 million, with a median of $15.6 million recorded in 2023.
  • The sharpest move saw Assets plummeted 64.06% in 2024, then skyrocketed 167.56% in 2025.
  • Over 5 years, Assets stood at $24.8 million in 2021, then dropped by 3.57% to $23.9 million in 2022, then crashed by 52.29% to $11.4 million in 2023, then tumbled by 41.75% to $6.6 million in 2024, then surged by 146.12% to $16.3 million in 2025.
  • According to Business Quant data, Assets over the past three periods came in at $16.3 million, $18.7 million, and $10.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.